Showing 4791-4800 of 5771 results for "".
- ImprimisRx to Provide Healthcare Professionals With Telemedicine Serviceshttps://modernod.com/news/imprimisrx-to-provide-healthcare-professionals-with-telemedicine-services/2477446/ImprimisRx, a wholly-owned subsidiary of Harrow Health, announced that they have entered into an exclusive agreement with Doxy.me, a full-service telemedicine solution. The agreement will provide all ImprimisRx ophthalmology, optometry, and wellness practices with the Clinic level
- FDA Approves Genentech’s Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumoniahttps://modernod.com/news/fda-approves-genentechs-clinical-trial-for-actemra-to-treat-hospitalized-patients-with-severe-covid-19-pneumonia/2477442/Genentech announced Monday that the FDA has approved a randomized, double-blind, placebo-controlled phase 3 clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate the safety and efficacy of intravenous Actemra (tocilizumab) plus standar
- My Eyelab and Stanton Optical to Offer Only Telehealth in Response to COVID-19 Crisishttps://modernod.com/news/my-eyelab-and-stanton-optical-to-offer-only-telehealth-in-response-to-covid-19-crisis/2477438/My Eyelab and Stanton Optical, retail brands of Now Optics, announced that in response to the COVID-19 crisis, they will immediately be offering only telehealth eyecare at 119 participating locations across the nation, according to a
- Adaptive Biotechnologies and Microsoft Expand Partnership to Decode COVID-19 Immune Response and Provide Open Data Accesshttps://modernod.com/news/adaptive-biotechnologies-and-microsoft-expand-partnership-to-decode-covid-19-immune-response-and-provide-open-data-access/2477435/Adaptive Biotechnologies and Microsoft announced they will leverage their existing partnership mapping population-wide adaptive immune responses to diseases at scale to study COVID-19. Finding the relevant immune response signature may advance solutions to diagnose, treat and prevent the disease,
- Bayer Partners With U.S. Government on Major Product Donation to Fight Coronavirushttps://modernod.com/news/bayer-partners-with-u-s-government-on-major-product-donation-to-fight-coronavirus/2477417/Bayer announced it is joining the U.S. Government’s fight against COVID-19 with a donation of 3 million tablets of the drug Resochin (chloroquine phosphate). Resochin, a product discovered by Bayer in 1934 and indicated for prevention and treatment of malaria, also appears to have br
- State Department to Tell Americans Don’t Travel Abroad, Come Home If Overseashttps://modernod.com/news/state-department-to-tell-americans-dont-travel-abroad-come-home-if-overseas/2477418/The State Department is set to announce a Level 4 travel advisory applying to all international travel, its most severe warning, three individuals with knowledge of the pending announcement said, according to a Politico
- Avellino Expands Production of Genetic Test Kits for Coronavirus Detectionhttps://modernod.com/news/avellino-expands-production-of-genetic-test-kits-for-coronavirus-detection/2477415/Avellino announced that it is adding additional production shifts for its newly developed coronavirus diagnostic, the Avellino SARS-CoV-2/COVID-19 test. The AvellinoCoV2 ultra-rapid genetic test is in increasing demand by health systems, public health services, and first-responders because of its
- Roche Initiates Phase 3 Trial of Actemra/RoActemra in Patients With Severe COVID-19 Pneumoniahttps://modernod.com/news/roche-initiates-phase-3-trial-of-actemra-roactemra-in-patients-with-severe-covid-19-pneumonia/2477410/Roche announced it is working with the FDA to initiate a randomized, double-blind, placebo-controlled phase 3 clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Services Office of th
- Quidel Receives Emergency Use Authorization for Molecular COVID-19 Diagnostic Assayhttps://modernod.com/news/quidel-receives-emergency-use-authorization-for-molecular-covid-19-diagnostic-assay/2477407/Quidel, a provider of rapid diagnostic testing solutions, announced that the company has received Emergency Use Authorization (EUA) from the FDA to market its Lyra SARS-CoV-2 Assay, a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal or
- Lenstec Submits Premarket Approval Application to FDA for SBL-3 IOLhttps://modernod.com/news/lenstec-submits-premarket-approval-application-to-fda-for-sbl3-iol/2477408/Lenstec has announced its has submitted a premarket approval (PMA) application to the FDA for the SBL-3 IOL. The Lenstec SBL-3 (segmented bifocal lens) is an asymmetric multifocal refractive IOL utilizing a 3-diopter add with a transition zone connecting the distanc